Navigation Links
PathSensors, Inc. Announced the Development of a SARS-CoV-2 Biosensor
Date:3/27/2020

PathSensors Inc, a Baltimore biotechnology company, announced today that they are developing a CANARY ™ biosensor to detect the Novel SARS Coronavirus (SARS-CoV-2), the causal agent for the coronavirus disease COVID–19. The biosensor will be available for research purposes in May 2020 and validation data on the new SARS-CoV-2 product will be available June 2020.

CANARY ™ technology provides a unique opportunity to reduce the impending public health impact of COVID-19 with rapid results and high specificity. The initial application for this PathSensors product will be for testing of environmental swabs and air monitoring in sensitive spaces such as hospitals, offices, food services, etc. PathSensors will continue to advance the assay’s capabilities as the novel virus is further characterized. As the SARS-CoV-2 biosensor is commercialized, PathSensors expects new uses to emerge, such as rapid specimen screening.

Third-party laboratory validations have demonstrated that commercially available CANARY ™ products are highly sensitive and specific. PathSensors offers three instrumentation platforms that are easy to use and typically generate test results in less than 5 minutes. PathSensors expects the SARS-CoV-2 product to be a valuable tool for fighting the spread of COVID-19.

An expert in virology and biological threats, Dr. David Hodge was involved in commissioning and overseeing a third-party evaluation of CANARY ™ technology while working at the Department of Homeland Security as the Senior Program Manager for Basic Research and Assay Development. “Our evaluation of CANARY™ technology resulted in promising sensitivity of detection data," said Dr. Hodge, PathSensors’ Scientific Advisor. "A SARS-CoV-2 assay would be a powerful solution to a critical problem."

“PathSensors has a long history of manufacturing rapid and highly sensitive detection kits for dangerous biologic agents such as anthrax, orthopox, ricin, listeria, and many others. We expect this new SARS-CoV-2 assay to dramatically expand the tools available to public health agencies fighting this pandemic” said Ted Olsen, PathSensors’ President.

About COVID-19
A novel coronavirus was discovered in late 2019 in China before spreading around the world. The disease, COVID-19, causes severe pneumonia-like symptoms and can be spread via human-to-human transmission prior to any symptoms. Coronaviruses are a family of viruses that cause diseases including Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). There is still much to learn about the novel coronavirus and the impacts of COVID-19 on global health.

About CANARY Technology
CANARY ™ is a biosensor technology that delivers extremely rapid detection of pathogens with high sensitivity and specificity. Originally developed by scientists at MIT–Lincoln Laboratory to combat bioterrorism threats, CANARY ™ technology has been licensed and commercialized by PathSensors, Inc.

About PathSensors, Inc.
PathSensors is a leading environmental testing company, built on CANARY ™ technology which is exclusively licensed from MIT-Lincoln Laboratory. CANARY ™ offers cutting-edge pathogen detection capabilities to a variety of industries including food safety, agriculture, and bioterrorism. The company’s mission is to make the world a safer place by detecting pathogens that can cause sickness or worse while creating high technology jobs in the state of Maryland.

Author:
Simone Stanley
Business Development Associate
(443) 877-4015
sstanley@pathsensors.com

Contact:
Joe Kennedy
Sales Manager
(443) 887-4005
jkennedy@pathsensors.com

Read the full story at https://www.prweb.com/releases/pathsensors_inc_announced_the_development_of_a_sars_cov_2_biosensor/prweb17001174.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. MARC travel awards announced for: 2014 SACNAS National Conference
2. MARC travel awards announced for: Society of Leukocyte Biology 2014 Joint Meeting
3. MARC travel awards announced for: American Society of Human Genetics 2014 Annual Meeting
4. MARC travel awards announced for GSA: Mouse Molecular Genetics Conference
5. MARC travel awards announced for: ACSM conference on integrative physiology of exercise
6. MARC travel awards announced for FASEB grant writing & practical exercises workshop
7. Space Station top results for biotechnology, health and education announced
8. 2013s most compelling International Space Station results announced
9. MARC travel awards announced for the 47th Annual Meeting of SSR
10. MARC travel awards announced for GSA: Xenopus Conference
11. MARC travel awards announced for ISCB, 22nd ISMB Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2020)... ... May 13, 2020 , ... ... Bonlacta™, its latest enzyme for the lactose-free dairy market. This unique product allows ... of lactose-free dairy products at competitive costs across North America. , Among the ...
(Date:5/11/2020)... ... 2020 , ... Octagos Health, a Houston-based company, recently launched ... The Octagos software allows healthcare professionals access to cardiac patients’ pacemaker, defibrillator or ... remote transmissions and at the same time provides real-time patient insights and analytics ...
(Date:5/6/2020)... BALTIMORE (PRWEB) , ... May ... ... today that Brevitest Technologies (Houston, Texas, http://www.brevitest.com ) will become the ... Port Covington region of Baltimore’s Inner Harbor. , Brevitest has developed a ...
Breaking Biology News(10 mins):
(Date:4/26/2020)... YORK (PRWEB) , ... April 23, 2020 , ... ... the Azure Marketplace today, an online store providing applications and services for use ... with certain well-defined business needs to sign up online for a built-for-purpose customer ...
(Date:4/22/2020)... ... April 21, 2020 , ... Ripple Science ... Many clinical trial teams are working remotely and have paused patient visits, forcing ... researchers continue their research during this uncertain time by giving research teams free ...
(Date:4/1/2020)... ... March 30, 2020 , ... Kinetic Vet, an animal health ... spray-on antimicrobial solution. As a first-of-its-kind technology within the animal health industry, ... microorganisms for up to 90 days. , In addition to reducing the cross ...
(Date:4/1/2020)... ... March 31, 2020 , ... Bedoukian Research, ... of a Joint Development Agreement that builds on each company’s expertise in developing ... leader in the supply of high-quality insect pheromones as well as flavors and ...
Breaking Biology Technology: